By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 113.00 |
Change Today | $ 0.54 |
% Change | 0.48 % |
52 Week High | $117.41 |
52 Week Low | $63.15 |
Volume | 6,152,957 |
Shares Issued | 1,246.00m |
Market Cap | $140,798m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 9 |
Neutral | 8 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
16:00 | 885,810 @ $113.00 |
15:59 | 300 @ $112.97 |
15:59 | 914 @ $112.97 |
15:59 | 100 @ $112.97 |
15:59 | 883 @ $112.97 |
You are here: research